Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
jRCT1061250070Recruiting
Randomised, double-blind trial of lidocaine in Cervical Cancer (CC) (2 arms). Primary endpoint: Primary: NRS at Tandem insertion (T2). Started Dec 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on jRCT1061250070.